(VRDN) Viridian Therapeutics - Performance 10.7% in 12m
VRDN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-3.57%
#36 in Peer-Group
Rel. Strength
67.26%
#2517 in Stock-Universe
Total Return 12m
10.69%
#46 in Peer-Group
Total Return 5y
2.26%
#31 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 25.71 USD |
| 52 Week Low | 11.02 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 92.77 |
| Buy/Sell Signal +-5 | -0.21 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VRDN (10.7%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
1.62% | -10.4% | 150% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-2.07% | 25.1% | -6.95% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.57% | 27.9% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: VRDN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VRDN
| Total Return (including Dividends) | VRDN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 2.01% | 3.06% | 3.54% |
| 3 Months | 27.03% | 12.25% | 16.07% |
| 12 Months | 10.69% | -13.98% | 12.18% |
| 5 Years | 2.26% | -27.36% | 107.69% |
| Trend Score (consistency of price movement) | VRDN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 43.1% | 65.7% | 91.4% |
| 3 Months | 84.9% | 79.4% | 97.5% |
| 12 Months | -48% | -87.3% | 46.7% |
| 5 Years | 3.5% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th59.00 | -1.02% | -1.48% |
| 3 Month | %th62.50 | 13.17% | 9.45% |
| 12 Month | %th77.50 | 28.67% | -1.33% |
| 5 Years | %th85.00 | 40.78% | -50.76% |
FAQs
Does Viridian Therapeutics (VRDN) outperform the market?
Yes,
over the last 12 months VRDN made 10.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -13.98%.
Over the last 3 months VRDN made 27.03%, while XBI made 12.25%.
Performance Comparison VRDN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VRDN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1% | -1.5% | -12.1% | -1% |
| US NASDAQ 100 | QQQ | 0.5% | -2.3% | -14.5% | -2% |
| German DAX 40 | DAX | 2% | 0.5% | -22.9% | -18% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.5% | -2.9% | -16.1% | -9% |
| Hongkong Hang Seng | HSI | 0.4% | -0.4% | -34.1% | -24% |
| India NIFTY 50 | INDA | 2.8% | 1.4% | -13.5% | 14% |
| Brasil Bovespa | EWZ | 5.6% | 5% | -24.2% | 10% |
VRDN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.1% | 0.2% | -16.2% | -13% |
| Consumer Discretionary | XLY | 0.7% | -0.6% | -3.4% | -5% |
| Consumer Staples | XLP | 2.9% | 2.8% | -12.8% | 4% |
| Energy | XLE | 3.2% | 2.3% | -1.9% | 13% |
| Financial | XLF | 2.4% | -0.6% | -11.6% | -11% |
| Health Care | XLV | 3.1% | 3.8% | -1.7% | 19% |
| Industrial | XLI | 0.6% | -2.7% | -18% | -11% |
| Materials | XLB | 3.6% | 0.3% | -9.9% | 10% |
| Real Estate | XLRE | 1.6% | 2.6% | -10.9% | 4% |
| Technology | XLK | 0.7% | -4.3% | -17.9% | -0% |
| Utilities | XLU | 0.3% | 0.1% | -14.8% | -11% |
| Aerospace & Defense | XAR | -1.8% | -7.2% | -32.7% | -38% |
| Biotech | XBI | -0.1% | -1.1% | -3.5% | 25% |
| Homebuilder | XHB | 2.7% | -3.5% | 1.3% | 18% |
| Retail | XRT | 2.2% | -0.9% | -7.9% | 6% |
VRDN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.5% | 6.25% | 4.27% | 17% |
| Natural Gas | UNG | -3.5% | 10.5% | 12.2% | 3% |
| Gold | GLD | 0.5% | 3.6% | -29.7% | -26% |
| Silver | SLV | -1.6% | -1.7% | -29% | -12% |
| Copper | CPER | -0.3% | -11.6% | -30.8% | -12% |
VRDN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.5% | 2.2% | -6.6% | 15% |
| iShares High Yield Corp. Bond | HYG | 1.5% | 1.1% | -10.1% | 2% |